Home » Topics » BioWorld Science

BioWorld Science
RSS

Licensing opportunity from NIH: novel vacuolar-type H+-ATPase inhibitors

July 6, 2001

Treatments for prostaglandin-mediated diseases in development at Merck Frosst

July 5, 2001

Metalloprotease inhibitors with therapeutic potential discovered at Roche

July 5, 2001

Novel compounds synthesized at Fujimoto useful for hyperlipidemia

July 5, 2001

Merck KGaA presents new modified EPO forms

July 5, 2001

Antibacterial and antiprotozoal erythromycin-based compounds

July 5, 2001

Human fibroblast growth factor gene and use in cirrhosis and cancer

July 5, 2001

Schering AG creates new company

July 5, 2001

Dianon Systems to acquire UroCor

July 5, 2001

Patient enrollment complete in VALIANT trial of Diovan for long-term survival following MI

July 5, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...